Please upgrade your browser.
The results of the new study, based on population samples from throughout the U.S., will be presented this week at the American Urological Associations Annual Meeting in Atlanta.
An increasingly common and safer type of surgery for kidney cancer is not as likely to be used for older, sicker and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, according to a new study by researchers at Henry Ford Hospital.
Data from Kidney Cancer Portfolio Further Demonstrate Efficacy and Safety Across Multiple Lines of Therapy.
Sunitinib is a multi-targeted tyrosine kinase inhibitor that is effective for advanced renal cell carcinoma. However, sunitinib often causes hypothyroidism. In this study, we report eight cases with thyroid dysfunction that occurred during sunitinib treatment for advanced renal cell carcinoma.
Survival rates have risen dramatically for many types of cancer but have hardly improved for others, BBC News reported.
Speak to one of the Oncology Certified Nurses available through SUTENT In Touch. Call 1-877-5-SUTENT (1-877-578-8368). Nurses are available to talk from 9:30 am to 7 pm ET, Monday through Friday.
Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells.
A chemical used to make oil and grease-repellent coatings for food packaging by DuPont has a probable link to kidney and testicular cancer, according to an independent science panel.
Galena Biopharma (Nasdaq:GALE - News), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced the appointment of Robert Figlin, M.D., F.A.C.P. to the Company's Scientific Advisory Board (SAB). [Ed. note: Dr. Figlin is an adviser to the Kidney Cancer Association]
This tax is especially pernicious because it is assessed on sales, not profits. To put this in perspective, imagine that you've manufactured medical devices and had sales of $1 million, after all your costs and expenseseverything from materials and labor to research and developmentyour profit was $100,000. The excise tax would be $23,000, wiping out almost 25% of your profits.
|Powered by NeonCRM|